These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6286400)

  • 21. Clinical evaluation of tissue plasminogen activator (t-PA) levels in patients with liver diseases.
    Okabe K; Kato I; Sato S; Kashiwabara T; Furuta S; Sato H; Tanikawa K; Kumashiro R; Kanayama M
    Gastroenterol Jpn; 1992 Feb; 27(1):61-8. PubMed ID: 1313384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and urinary methionine concentrations in severe hepatic failure of viral hepatitis. Relevance to development of encephalopathy and prognosis.
    Kaldor J; Spelman DW; Metcalf WR; Lucas CR
    Med J Aust; 1986 Jul; 145(2):76-9. PubMed ID: 3736469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Abnormal amino acid metabolism in serious liver diseases: branched chain amino acid and aromatic amino acid metabolism].
    Sato Y
    Nihon Rinsho; 1982; 40(4):776-83. PubMed ID: 7098048
    [No Abstract]   [Full Text] [Related]  

  • 24. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
    Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
    Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The diagnostic value of determining serum-mercaptans in liver disease (author's transl)].
    Brunner G; Scharff P
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1796-800. PubMed ID: 710290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma.
    Chio LF; Oon CJ
    Cancer; 1979 Feb; 43(2):596-604. PubMed ID: 84707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients.
    Ishibashi K; Nishikawa A; Hayashi N; Kasahara A; Sato N; Fujii S; Kamada T; Taniguchi N
    Clin Chim Acta; 1989 Dec; 185(3):325-32. PubMed ID: 2482796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristic features of plasma amino acid, plasma pancreatic glucagon, serum insulin concentrations in cirrhotic patients with histories of chronic alcohol consumption.
    Nakatsukasa H; Watanabe A; Kobayashi M; Shiota T; Fujiwara M; Takei N; Yamauchi Y; Hayashi S; Nagashima H
    Gastroenterol Jpn; 1984 Apr; 19(2):110-5. PubMed ID: 6376263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical evaluation of serum alpha-1-antichymotrypsin levels in liver disease and cancers.
    Matsuzaki S; Iwamura K; Itakura M; Kamiguchi H; Katsunuma T
    Gastroenterol Jpn; 1981 Dec; 16(6):582-91. PubMed ID: 6174385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels.
    Nakayama A; Fukuda H; Ebara M; Hamasaki H; Nakajima K; Sakurai H
    Biol Pharm Bull; 2002 Apr; 25(4):426-31. PubMed ID: 11995918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma amino acid patterns in hepatic encephalopathy of differing etiology.
    Rosen HM; Yoshimura N; Hodgman JM; Fischer JE
    Gastroenterology; 1977 Mar; 72(3):483-7. PubMed ID: 832796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of branched chain amino acid infusion on glucose metabolism in cirrhotic patients with encephalopathy.
    Morioka S; Kanai K; Kako M; Nakajima T; Yoshimi T; Masaka M; Sudo K; Kanno T
    Gastroenterol Jpn; 1983 Dec; 18(6):553-9. PubMed ID: 6368305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parenteral nutrition and coma therapy with amino acids in hepatic failure.
    Striebel JP; Holm E; Lutz H; Storz LW
    JPEN J Parenter Enteral Nutr; 1979; 3(4):240-6. PubMed ID: 113592
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum levels of estrogens and testosterone in cirrhotic men with and without hepatocellular carcinoma.
    Nagasue N; Ogawa Y; Yukaya H; Ohta N; Ito A
    Gastroenterology; 1985 Mar; 88(3):768-72. PubMed ID: 2981753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
    Holecek M
    Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. I. Clinical aspects.
    Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Kimoto M; Kawakami S; Miyoshi H; Kubozono O
    Dig Dis Sci; 1991 Jun; 36(6):780-4. PubMed ID: 1827761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of plasma thrombomodulin (TM) levels in patients with liver disease].
    Akiyama K; Nakamura K; Makino I
    Nihon Shokakibyo Gakkai Zasshi; 1992 Oct; 89(10):2559-67. PubMed ID: 1328724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
    Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
    Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of methanethiol in the pathogenesis of hepatic encephalopathy.
    Blom HJ; Ferenci P; Grimm G; Yap SH; Tangerman A
    Hepatology; 1991 Mar; 13(3):445-54. PubMed ID: 1999315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.